GSK’s Nucala and Blenrep receive regulatory boost in US and China – Shares Magazine

… chronic obstructive pulmonary disease. The drug maker said Nucala could be the first approved biologic treatment with monthly dosing for COPD …

Share on Facebook

Tweet

Follow us

Save